During the past decade, UNMC Eppley Cancer Center at the University of Nebraska Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 28 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UNMC Eppley Cancer Center at the University of Nebraska Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 32 trials, followed by "University of Nebraska" with 26 trials sponsored, "Children's Oncology Group" with 20 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored and "Radiation Therapy Oncology Group" with 7 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNMC Eppley Cancer Center at the University of Nebraska Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 96 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator and "Eastern Cooperative Oncology Group" with 4 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "UNMC Eppley Cancer Center at the University of Nebraska Medical Center" are "Lymphoma" (24 trials), "Leukemia" (16 trials), "Breast Cancer" (13 trials), "Lung Cancer" (7 trials) and "Myelodysplastic Syndromes" (6 trials). Many other conditions were trialed in "UNMC Eppley Cancer Center at the University of Nebraska Medical Center" in a lesser frequency.

Most popular intervention types in "UNMC Eppley Cancer Center at the University of Nebraska Medical Center" are "Drug" (81 trials), "Biological" (37 trials), "Procedure" (32 trials), "Radiation" (28 trials) and "Other" (24 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (24 trials), "doxorubicin hydrochloride" (19 trials), "radiation therapy" (18 trials), "etoposide" (14 trials) and "filgrastim" (13 trials). Other intervention names were less common.

The vast majority of trials in "UNMC Eppley Cancer Center at the University of Nebraska Medical Center" are 84 trials for "All" genders, 15 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "UNMC Eppley Cancer Center at the University of Nebraska Medical Center". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 82 completed trials in UNMC Eppley Cancer Center at the University of Nebraska Medical Center, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in UNMC Eppley Cancer Center at the University of Nebraska Medical Center, 13 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".